Literature DB >> 10984616

Unique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 ('casein kinase-2').

O Marin1, S Sarno, M Boschetti, M A Pagano, F Meggio, V Ciminale, D M D'Agostino, L A Pinna.   

Abstract

The HIV-1 Rev transactivator is phosphorylated in vitro by protein kinase CK2 at two residues, Ser-5 and Ser-8; these sites are also phosphorylated in vivo. Here we show that the mechanism by which CK2 phosphorylates Rev is unique in several respects, notably: (i) it is fully dependent on the regulatory, beta-subunit of CK2; (ii) it relies on the integrity of an acidic stretch of CK2 beta which down-regulates the phosphorylation of other substrates; (iii) it is inhibited in a dose-dependent manner by polyamines and other polycationic effectors that normally stimulate CK2 activity. In contrast, a peptide corresponding to the amino-terminal 26 amino acids of Rev, including the phosphoacceptor site, is readily phosphorylated by the catalytic subunit of CK2 even in the absence of the beta-subunit. These data, in conjunction with the observation that two functionally inactive derivatives of Rev with mutations in its helix-loop-helix motif are refractory to phosphorylation, indicate the phosphorylation of Rev by CK2 relies on conformational features of distinct regions that are also required for the transactivator's biological activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984616     DOI: 10.1016/s0014-5793(00)01971-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  HIV-1 Rev transactivator: a beta-subunit directed substrate and effector of protein kinase CK2.

Authors:  F Meggio; O Marin; M Boschetti; S Sarno; L A Pinna
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

2.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Autophosphorylation at the regulatory beta subunit reflects the supramolecular organization of protein kinase CK2.

Authors:  Mario A Pagano; Stefania Sarno; Giorgia Poletto; Giorgio Cozza; Lorenzo A Pinna; Flavio Meggio
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

4.  Autocatalytic tyrosine-phosphorylation of protein kinase CK2 alpha and alpha' subunits: implication of Tyr182.

Authors:  A Donella-Deana; L Cesaro; S Sarno; A M Brunati; M Ruzzene; L A Pinna
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

5.  Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology.

Authors:  Sheila A Barber; Linda Bruett; Brian R Douglass; David S Herbst; M Christine Zink; Janice E Clements
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Structure-based discovery of novel flavonol inhibitors of human protein kinase CK2.

Authors:  Andriy G Golub; Volodymyr G Bdzhola; Yaroslav V Kyshenia; Vladislav M Sapelkin; Andriy O Prykhod'ko; Olexander P Kukharenko; Olga V Ostrynska; Sergiy M Yarmoluk
Journal:  Mol Cell Biochem       Date:  2011-07-07       Impact factor: 3.396

Review 7.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

8.  Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells.

Authors:  Cinzia Franchin; Christian Borgo; Luca Cesaro; Silvia Zaramella; Jordi Vilardell; Mauro Salvi; Giorgio Arrigoni; Lorenzo A Pinna
Journal:  Cell Mol Life Sci       Date:  2017-11-09       Impact factor: 9.261

9.  Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole.

Authors:  R Battistutta; E De Moliner; S Sarno; G Zanotti; L A Pinna
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

10.  Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2.

Authors:  Mario A Pagano; Oriano Marin; Giorgio Cozza; Stefania Sarno; Flavio Meggio; Kate J Treharne; Anil Mehta; Lorenzo A Pinna
Journal:  Biochem J       Date:  2010-01-27       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.